Perihilar cholangiocarcinoma;
Bile duct cancer;
Klatskin tumor;
Resectability;
Surgery;
Limits;
D O I:
10.1159/000433482
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Introduction: Perihilar cholangiocarcinoma is the most frequent cholangiocarcinoma and poses difficulties in preoperative evaluation. For its therapy, often major hepatic resections as well as resection and reconstruction of the hepatic artery or the portal vein are necessary. In the last decades, great advances were made in both the surgical procedures and the perioperative anesthetic management. In this article, we describe from our point of view which facts represent the limits for curative (R0) resection in perihilar cholangiocarcinoma. Methods: Retrospective data of a 6-year period (2008-2014) was collected in an SPSS 22 database and further analyzed with focus on the surgical approach and the postoperative as well as histological results. Results: Out of 96 patients in total we were able to intend a curative resection in 73 patients (76%). In 58/73 (79.5%) resections an R0 situation could be reached (R1 n = 14; R2 n = 1). 23 patients were irresectable because of peritoneal carcinosis (n = 8), broad infiltration of major blood vessels (n = 8), bilateral advanced tumor growth to the intrahepatic bile ducts (n = 3), infiltration of the complete liver hilum (n = 2), infiltration of the gallbladder (n = 1), and liver cirrhosis (n = 1). Patients with a T4 stadium were treated with curative intention twice, and in each case an R1 resection was achieved. Most patients with irresectable tumors can be suspected to have a T4 stadium as well. In a T3 situation (n = 6) we could establish five R0 resections and one R1 resection. Conclusion: The limit of surgical resection for bile duct cancer is the advanced tumor stage (T stadium). While in a T3 stadium an R0 resection is possible in most cases, we were not able to perform an R0 resection in a T4 stadium. From our point of view, early T stadium cannot usually be estimated through expanded diagnostics but only through surgical exploration.
机构:
Lille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
Univ Lille, Lille, FranceLille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
Khodr, Justine
Truant, Stephanie
论文数: 0引用数: 0
h-index: 0
机构:
Lille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
Univ Lille, Lille, FranceLille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
Truant, Stephanie
El Amrani, Mehdi
论文数: 0引用数: 0
h-index: 0
机构:
Lille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
Univ Lille, Lille, FranceLille Univ Hosp, Dept Digest Surg & Transplantat, Rue Michel Polonovski, F-59037 Lille, France
机构:
Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, JapanUniv Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, Japan
Seyama, Yasuji
Makuuchi, Masatoshi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, JapanUniv Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, Japan
机构:
Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul 120752, South KoreaYonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul 120752, South Korea
Lee, Sung Hwan
论文数: 引用数:
h-index:
机构:
Lim, Jin Hong
Park, Joon Seong
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South KoreaYonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul 120752, South Korea
Park, Joon Seong
论文数: 引用数:
h-index:
机构:
Yoon, Dong Sup
Kim, Kyung Sik
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul 120752, South Korea
Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, 50-1 Yonsei Ro, Seoul 120752, South KoreaYonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul 120752, South Korea